Literature DB >> 2331700

Conformation of the pentasaccharide corresponding to the binding site of heparin for antithrombin III.

M Ragazzi1, D R Ferro, B Perly, P Sinaÿ, M Petitou, J Choay.   

Abstract

The conformation in solution of the pentasaccharide methyl glycoside (As-G-A*-Is-AM; 1), which represents the binding site of heparin for Antithrombin III, has been investigated using molecular mechanics and 1H-n.m.r. spectroscopy. The pentasaccharide has a rather rigid (As-G-A*) and a more flexible (Is-AM) region. A simplified model of 1, comprising two conformations, corresponding to the 1C4 and the 2S0 forms of the iduronate residue, and modified at the G-A* glycosidic linkage with respect to the energy minimum, reproduces most of the observed 3J values and n.O.e. enhancements. The possible role in the binding to Antithrombin III of a low-energy conformer, not observed in solution, is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2331700     DOI: 10.1016/0008-6215(90)84165-q

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  11 in total

1.  Finding a needle in a haystack: development of a combinatorial virtual screening approach for identifying high specificity heparin/heparan sulfate sequence(s).

Authors:  Arjun Raghuraman; Philip D Mosier; Umesh R Desai
Journal:  J Med Chem       Date:  2006-06-15       Impact factor: 7.446

2.  Solution dynamics of the 1,2,3,4,6-penta-O-acetyl-alpha-D-idopyranose ring.

Authors:  D A Horita; P J Hajduk; L E Lerner
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

3.  Perspective on computational simulations of glycosaminoglycans.

Authors:  Balaji Nagarajan; Nehru Viji Sankaranarayanan; Umesh R Desai
Journal:  Wiley Interdiscip Rev Comput Mol Sci       Date:  2018-09-10

4.  Conformation of heparin pentasaccharide bound to antithrombin III.

Authors:  M Hricovíni; M Guerrini; A Bisio; G Torri; M Petitou; B Casu
Journal:  Biochem J       Date:  2001-10-15       Impact factor: 3.857

5.  Solution structures of chemoenzymatically synthesized heparin and its precursors.

Authors:  Zhenqing Zhang; Scott A McCallum; Jin Xie; Lidia Nieto; Francisco Corzana; Jesús Jiménez-Barbero; Miao Chen; Jian Liu; Robert J Linhardt
Journal:  J Am Chem Soc       Date:  2008-09-04       Impact factor: 15.419

6.  N.m.r. and molecular-modelling studies of the solution conformation of heparin.

Authors:  B Mulloy; M J Forster; C Jones; D B Davies
Journal:  Biochem J       Date:  1993-08-01       Impact factor: 3.857

7.  Structural and functional properties of heparin analogues obtained by chemical sulphation of Escherichia coli K5 capsular polysaccharide.

Authors:  N Razi; E Feyzi; I Björk; A Naggi; B Casu; U Lindahl
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

8.  Heparin binding domain peptides of antithrombin III: analysis by isothermal titration calorimetry and circular dichroism spectroscopy.

Authors:  R Tyler-Cross; M Sobel; D Marques; R B Harris
Journal:  Protein Sci       Date:  1994-04       Impact factor: 6.725

9.  Extended Physicochemical Characterization of the Synthetic Anticoagulant Pentasaccharide Fondaparinux Sodium by Quantitative NMR and Single Crystal X-ray Analysis.

Authors:  William de Wildt; Huub Kooijman; Carel Funke; Bülent Üstün; Afranina Leika; Maarten Lunenburg; Frans Kaspersen; Edwin Kellenbach
Journal:  Molecules       Date:  2017-08-17       Impact factor: 4.411

10.  Conformational Modulation of Iduronic Acid-Containing Sulfated Glycosaminoglycans by a Polynuclear Platinum Compound and Implications for Development of Antimetastatic Platinum Drugs.

Authors:  Anil K Gorle; Thomas Haselhorst; Samantha J Katner; Arun V Everest-Dass; James D Hampton; Erica J Peterson; Jennifer E Koblinski; Eriko Katsuta; Kazuaki Takabe; Mark von Itzstein; Susan J Berners-Price; Nicholas P Farrell
Journal:  Angew Chem Int Ed Engl       Date:  2020-12-23       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.